Basal Bolus Versus Basal Insulin in Type 2 Diabetes Mellitus (T2DM)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 375 participants.
Also called NCT00979628
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 375 participants
- Registry
-
NCT00979628
-
- Main results
- Randomized study comparing a Basal-bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial
- Other papers using this trial's data
- Hospital discharge algorithm based on admission HbA1c for the management of patients with type 2 diabetes
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT00979628. Randomized; no masking; primary purpose treatment. Start 2010-01 (registry gives no type); primary completion 2012-03 (actual). Results posted on 2014-04-24.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Basal Bolus Versus Basal Insulin in Type 2 Diabetes Mellitus (T2DM)
- Acronym
- Basal-Plus
- Condition
- Type 2 Diabetes
- Condition
- Hyperglycemia
- Intervention (Drug)
- sliding scale regular insulin (SSRI)
- Intervention (Drug)
- Basal Bolus
- Intervention (Drug)
- Basal Plus
- Lead sponsor
- Guillermo Umpierrez, MD
- Collaborator
- Sanofi
- Collaborator
- Medical University of South Carolina
- Collaborator
- Texas A&M University
Record details
- Record id
cardio:ct-nct00979628- Content hash
47dba4df0bbeeed5719154573774a8e370b2a0fda544cda48102989e1fc44a2b